189 related articles for article (PubMed ID: 34864270)
1. COVID-19 associated Rhino-Orbito-Cerebral Mucormycosis: Imaging spectrum and Clinico-radiological correlation- a single Centre experience.
Patel DD; Adke S; Badhe PV; Lamture S; Marfatia H; Mhatre P
Clin Imaging; 2022 Feb; 82():172-178. PubMed ID: 34864270
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of intracranial complications of rhino-orbito-cerebral mucormycosis - resurgence in the era of COVID-19 pandemic: a pictorial essay.
Kaushik KS; Ananthasivan R; Acharya UV; Rawat S; Patil UD; Shankar B; Jose A
Emerg Radiol; 2021 Dec; 28(6):1097-1106. PubMed ID: 34605991
[TBL] [Abstract][Full Text] [Related]
3. Magnetic Resonance Imaging in Coronavirus Disease - 2019 Associated Rhino-Orbital-Cerebral Mucormycosis (CA-ROCM) - Imaging Analysis of 50 Consecutive Patients.
Yadav T; Tiwari S; Gupta A; Garg PK; Khera PS; Rajagopal R; Goyal A; Soni K; Chugh A; Jain V; Sureka B; Elhence P; Misra S
Curr Probl Diagn Radiol; 2022; 51(1):112-120. PubMed ID: 34802841
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India - Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1.
Sen M; Honavar SG; Bansal R; Sengupta S; Rao R; Kim U; Sharma M; Sachdev M; Grover AK; Surve A; Budharapu A; Ramadhin AK; Tripathi AK; Gupta A; Bhargava A; Sahu A; Khairnar A; Kochar A; Madhavani A; Shrivastava AK; Desai AK; Paul A; Ayyar A; Bhatnagar A; Singhal A; Nikose AS; Bhargava A; Tenagi AL; Kamble A; Nariani A; Patel B; Kashyap B; Dhawan B; Vohra B; Mandke C; Thrishulamurthy C; Sambare C; Sarkar D; Mankad DS; Maheshwari D; Lalwani D; Kanani D; Patel D; Manjandavida FP; Godhani F; Agarwal GA; Ravulaparthi G; Shilpa GV; Deshpande G; Thakkar H; Shah H; Ojha HR; Jani H; Gontia J; Mishrikotkar JP; Likhari K; Prajapati K; Porwal K; Koka K; Dharawat KS; Ramamurthy LB; Bhattacharyya M; Saini M; Christy MC; Das M; Hada M; Panchal M; Pandharpurkar M; Ali MO; Porwal M; Gangashetappa N; Mehrotra N; Bijlani N; Gajendragadkar N; Nagarkar NM; Modi P; Rewri P; Sao P; Patil PS; Giri P; Kapadia P; Yadav P; Bhagat P; Parekh R; Dyaberi R; Chauhan RS; Kaur R; Duvesh RK; Murthy R; Dandu RV; Kathiara R; Beri R; Pandit R; Rani RH; Gupta R; Pherwani R; Sapkal R; Mehta R; Tadepalli S; Fatima S; Karmarkar S; Patil SS; Shah S; Shah S; Shah S; Dubey S; Gandhi S; Kanakpur S; Mohan S; Bhomaj S; Kerkar S; Jariwala S; Sahu S; Tara S; Maru SK; Jhavar S; Sharma S; Gupta S; Kumari S; Das S; Menon S; Burkule S; Nisar SP; Kaliaperumal S; Rao S; Pakrasi S; Rathod S; Biradar SG; Kumar S; Dutt S; Bansal S; Ravani SA; Lohiya S; Ali Rizvi SW; Gokhale T; Lahane TP; Vukkadala T; Grover T; Bhesaniya T; Chawla U; Singh U; Une VL; Nandedkar V; Subramaniam V; Eswaran V; Chaudhry VN; Rangarajan V; Dehane V; Sahasrabudhe VM; Sowjanya Y; Tupkary Y; Phadke Y;
Indian J Ophthalmol; 2021 Jul; 69(7):1670-1692. PubMed ID: 34156034
[TBL] [Abstract][Full Text] [Related]
5. A fungal epidemic amidst a viral pandemic: Risk factors for development of COVID-19 associated rhino-orbital-cerebral mucormycosis in India.
Vasanthapuram VH; Gupta R; Adulkar N; Nair AG; Bradoo RA; Hegde R; Singh U; Tadepalli S; Mukherjee B; Kamal S; Alam MS; Rao R; Ananthakrishna S; Backiavathy V; Murthy AK; D'Cunha L; Dudeja G; Joji A; Kiran A; Koka K; Goswami Mukhopadhyay M; Nisar SP; Rao PR; Shinde CA
Orbit; 2023 Feb; 42(1):30-41. PubMed ID: 35192435
[TBL] [Abstract][Full Text] [Related]
6. Rhino-orbito-cerebral mucormycosis and its resurgence during COVID-19 pandemic: A review.
Karkhur S; Soni D; Chauhan K; Sarkar D; Gautam M; Verma S; Nyodu R; Yadav N; Sharma B
Indian J Ophthalmol; 2023 Jan; 71(1):39-56. PubMed ID: 36588206
[TBL] [Abstract][Full Text] [Related]
7. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
[TBL] [Abstract][Full Text] [Related]
8. Imaging findings in invasive rhino-orbito-cerebral mucormycosis in post-COVID-19 patients.
Jindal G; Sethi A; Bhargarva K; Sethi S; Mittal A; Singh U; Singh S; Shrivastava A
Proc (Bayl Univ Med Cent); 2022; 35(1):32-34. PubMed ID: 34970028
[TBL] [Abstract][Full Text] [Related]
9. The ROC Staging System for COVID-related Rhino-Orbital-Cerebral Mucormycosis.
Naik MN; Rath S
Semin Ophthalmol; 2022 Apr; 37(3):279-283. PubMed ID: 34260342
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 associated rhino-orbito-cerebral mucormycosis, risk factors and outcome predictors; a multicentric study.
Rajabi MT; Aghajani A; Rafizadeh SM; Jamshidian Tehrani M; Poursayed Lazarjani SZ; Keshmirshekan MM; Mohammadi A; Akrami A; Parandin MM; Rajabi MB; Hosseini SS; Akbari M
Int Ophthalmol; 2023 Apr; 43(4):1375-1386. PubMed ID: 36209307
[TBL] [Abstract][Full Text] [Related]
11. Surgical & medical management of ROCM (Rhino-orbito-cerebral mucormycosis) epidemic in COVID-19 era and its outcomes - a tertiary care center experience.
Soni K; Das A; Sharma V; Goyal A; Choudhury B; Chugh A; Kumar D; Yadav T; Jain V; Agarwal A; Garg M; Bhatnagar K; Elhence P; Bhatia PK; Garg MK; Misra S
J Mycol Med; 2022 May; 32(2):101238. PubMed ID: 34979299
[TBL] [Abstract][Full Text] [Related]
12. A retrospective analysis of eleven cases of invasive rhino-orbito-cerebral mucormycosis presented with orbital apex syndrome initially.
Jiang N; Zhao G; Yang S; Lin J; Hu L; Che C; Wang Q; Xu Q
BMC Ophthalmol; 2016 Jan; 16():10. PubMed ID: 26758904
[TBL] [Abstract][Full Text] [Related]
13. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control.
Mitra S; Janweja M; Sengupta A
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2417-2422. PubMed ID: 34309754
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 associated rhino-orbital-cerebral mucormycosis: An observational study from Eastern India, with special emphasis on neurological spectrum.
Dubey S; Mukherjee D; Sarkar P; Mukhopadhyay P; Barman D; Bandopadhyay M; Pandit A; Sengupta A; Das S; Ghosh S; Adhikari S; Biswas PS; Pal P; Roy H; Patra N; Das A; Sinha P; Mondal MK; Shrivastava SR; Bhattacharya K; Mukhopadhyay M; Ahmed K; Halder TK; Saha M; Ahmed K; Maity S; Mandal A; Chatterjee D; Saha S; Chunakar A; Saha A; Ray BK
Diabetes Metab Syndr; 2021; 15(5):102267. PubMed ID: 34509790
[TBL] [Abstract][Full Text] [Related]
15. Uncontrolled diabetes mellitus exacerbated by COVID-19-induced inflammation is the risk factor for COVID-19-associated rhino-orbito-cerebral mucormycosis: A matched pair case-control study.
Karat S; Lobo AC; Satish D; Devaraj R; Manjooran RR; Nithyanandam S
Indian J Ophthalmol; 2022 Aug; 70(8):3096-3101. PubMed ID: 35918980
[TBL] [Abstract][Full Text] [Related]
16. MR imaging spectrum in COVID associated Rhino-Orbito-Cerebral mucormycosis with special emphasis on intracranial disease and impact on patient prognosis.
Sehgal A; Kumar J; Garg A; Jain A; Meher R; Singh M; Goel R
Eur J Radiol; 2022 Jul; 152():110341. PubMed ID: 35569303
[TBL] [Abstract][Full Text] [Related]
17. Rhino-orbito-cerebral mucormycosis: patient characteristics in pre-COVID-19 and COVID-19 period.
Cherian LM; Varghese L; Rupa V; Bright RR; Abraham L; Panicker R; R N; Peter J; Nayak A; Shyam A; Varghese GM; Manesh A; Karuppusami R; George K; George T; Lenin A; Hansdak SG; I R; Michael JS; Ninan M; Thomas M; Kurian R; Mammen S; Kurien R
Rhinology; 2022 Dec; 60(6):427-434. PubMed ID: 36150158
[TBL] [Abstract][Full Text] [Related]
18. Orbital magnetic resonance imaging profile and clinicoradiological correlation in COVID-19-associated rhino-orbital-cerebral mucormycosis: A single-center study of 270 patients from North India.
Hada M; Gupta P; Bagarhatta M; Tripathy K; Harsh A; Khilnani K; Mendiratta K; Agarwal S; Chouhan JK; Bhandari S
Indian J Ophthalmol; 2022 Feb; 70(2):641-648. PubMed ID: 35086254
[TBL] [Abstract][Full Text] [Related]
19. Clinicoradiological profile and outcome of cavernous sinus syndrome with coronavirus disease-2019-associated rhino-orbito-cerebral mucormycosis.
Sulena S; Dhawan M; Singh N; Arora H; Singh G; Aggarwal V; Tapasvi C
J Neurosci Rural Pract; 2022; 13(4):730-739. PubMed ID: 36743739
[TBL] [Abstract][Full Text] [Related]
20. Predictors of disease severity in COVID-19 associated mucormycosis: impact of HbA1C levels, time lag to mucormycosis onset, and radiologic patterns of paranasal sinuses and spaces involvement.
Rao P; Rangankar V; Rohatgi S; Dubey P; Gitay A; Singh A; Jadhav SL; Nirhale S; Naphade P
Infect Dis (Lond); 2023 Nov; 55(11):755-766. PubMed ID: 37480325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
